Clinical presentation and diagnosis of multiple sclerosis.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 15 5 2021
Statut: ppublish

Résumé

The diagnosis of multiple sclerosis (MS) is through clinical assessment and supported by investigations. There is no single accurate and reliable diagnostic test. MS is a disease of young adults with a female predominance. There are characteristic clinical presentations based on the areas of the central nervous system involved, for example optic nerve, brainstem and spinal cord. The main pattern of MS at onset is relapsing-remitting with clinical attacks of neurological dysfunction lasting at least 24 hours. The differential diagnosis includes other inflammatory central nervous system disorders. Magnetic resonance imaging of the brain and lumbar puncture are the key investigations. New diagnostic criteria have been developed to allow an earlier diagnosis and thus access to effective disease modifying treatments.

Identifiants

pubmed: 32675142
pii: 20/4/380
doi: 10.7861/clinmed.2020-0292
pmc: PMC7385797
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-383

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Royal College of Physicians 2020. All rights reserved.

Références

Ann Neurol. 1983 Mar;13(3):227-31
pubmed: 6847134
Nat Rev Neurol. 2017 Sep;13(9):567-572
pubmed: 28799551
Neurology. 2014 Jul 15;83(3):278-86
pubmed: 24871874
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Neurology. 2019 May 28;92(22):1037-1038
pubmed: 31043473
Mult Scler. 2008 Nov;14(9):1157-74
pubmed: 18805839
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Pract Neurol. 2019 Jun;19(3):187-195
pubmed: 30530724
Lancet Neurol. 2016 Mar;15(3):292-303
pubmed: 26822746

Auteurs

Helen Ford (H)

Leeds Centre for Neurosciences, Leeds, UK helen.ford17@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH